1)日本医学放射線学会,日本放射線科専門医会・医会(編):画像診断ガイドライン,2013年版.金原出版,2013, pp 250-252, 314-315, 424-425
2)日本核医学会:FDG PET, PET/CT診療ガイドライン,2012[http://www.jsnm.org/files/pdf/guideline/2012/fdgpet_guideline2012_120912.pdf]
3)Suga T, Nakamoto Y, Saga T, et al:Prevalence of positive FDG-PET findings in patients with high CEA levels. Ann Nucl Med 24:433-439, 2010
F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Eur J Nucl Med Mol Imaging 80:1560-1571, 2011
5)Hahn S, Bauer S, Heusner TA, et al:Postoperative FDG-PET/CT staging in GIST:is there a benefit following R0 resection? Eur J Radiol 80:670-674, 2011
6)Shankar S, vanSonnenberg E, Desai J, et al:Gastrointestinal stromal tumor:new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 235:892-898, 2005
In-Pentetreotide uptake by neuroendocrine tumors. Ann Nucl Med 28:1004-1010, 2014
8)Ambrosini V, Fani M, Fanti S, et al:Radiopeptide imaging and therapy in Europe. J Nucl Med 52:42S-55S, 2011